President Donald Trump signed an executive order reclassifying marijuana from a Schedule I to a Schedule III substance, facilitating medical research and potentially alleviating tax burdens on the cannabis industry, though it won’t legalize recreational use. This policy shift faced opposition from Senator Ted Budd and others who argue marijuana remains dangerous. Additionally, Trump’s board at the Kennedy Center voted to rename it the “Trump Kennedy Center,” a move criticized by some Kennedy family members. Advocates condemned new Trump administration proposals that would restrict funding for gender-affirming care, labeling them harmful to LGBTQ+ youth.
